Bayer Aktiengesellschaft (ETR:BAYN)
28.56
+0.43 (1.51%)
Aug 22, 2025, 5:35 PM CET
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 10.74B EUR in the quarter ending June 30, 2025, a decrease of -3.63%. This brings the company's revenue in the last twelve months to 46.17B, down -1.99% year-over-year. In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B, down -2.16%.
Revenue (ttm)
46.17B
Revenue Growth
-1.99%
P/S Ratio
0.61
Revenue / Employee
515.59K
Employees
91,864
Market Cap
28.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.18B |
SCHOTT Pharma AG & Co. KGaA | 975.68M |
Bayer Aktiengesellschaft News
- 2 days ago - Bayer's E.L.Y. Wins “AI-based AgTech Solution of the Year” In 2025 AgTech Breakthrough Awards Program - GlobeNewsWire
- 5 days ago - Bayer reaches settlement in PCB exposure lawsuits from Seattle-area school - Seeking Alpha
- 5 days ago - Bayer settles Sky Valley cases over chemical PCB - Reuters
- 8 days ago - Bayer Aspirin Introduces Aspirina to the U.S. Pain Market - Wallstreet:Online
- 8 days ago - Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market - Business Wire
- 8 days ago - LumenHaus Powers Bayer 04 Leverkusen as Official Premium Partner for 2025/26 Season - GlobeNewsWire
- 10 days ago - Why are Indoco Remedies shares up 2% today? Explained - Business Upturn
- 11 days ago - Bayer and Kumquat Biosciences partner to develop cancer treatment - Seeking Alpha